Thursday, November 16, 2006
Back To Faculty Page: Print Current Session:
|
|
Thursday
SESSION X:
SUPERFICIAL FEMORAL ARTERY (SFA) AND CRURAL ARTERY TREATMENT: STATE-OF-THE-ART AND NEW ADJUNCTS (6- AND 7-MINUTE TALKS)
|
|
SESSION X SCHEDULE | |
9:50 AM - 9:57 AM | Natural History Of Patients With Arterial Insufficiency And Non-Healing Ulcers Treated Conservatively: How Does It Impact On Limb Salvage Results With Aggressive New Endo-Interventions And Are We Being Fooled Into Over-Treating? |
Presenters(s): Blair A. Keagy, M.D. | |
9:58 AM - 10:05 AM | Outcomes Of Infrainguinal Intervention: Beyond The Hype And Baloney - What Really Works And What Does Not? |
Presenters(s): Alan T. Hirsch, M.D. | |
10:06 AM - 10:13 AM | PTA vs. Stenting Of The SFA: Results Of The Resilient Randomized Trial |
Presenters(s): Barry T. Katzen, M.D. | |
10:14 AM - 10:21 AM | How To Avoid Fractures In SFA Stents And Will It Improve Results: Are Absorbable Stents The Answer? |
Presenters(s): Giancarlo Biamino, M.D. | |
10:22 AM - 10:28 AM | Role Of SFA Stents In 2006: How Well Do They Work? |
Presenters(s): Mark W. Mewissen, M.D. | |
10:29 AM - 10:35 AM | Do We Have The Right Stents For Femoropopliteal Lesions And 2-3 Year Results Of A Randomized Trial Comparing Absorbable Metal Stents To PTA Alone In Crural Arteries? |
Presenters(s): Marc Bosiers, M.D. | |
10:36 AM - 10:42 AM | 3-Year Trial Results Of Zilver Nitinol Stents For Long SFA Lesions (TASC C And D) |
Presenters(s): Marcelo Ferreira, M.D. | |
10:43 AM - 10:49 AM | Update On The Value And Limitations Of The Silverhawk Rotational Atherectomy Device For Treatment Of Infrainguinal Disease |
Presenters(s): Venkatesh G. Ramaiah, M.D. | |
10:50 AM - 10:56 AM | Midterm Results Of Rotational Atherectomy In Patients With TASC C Lesions Treated For Critical Ischemia |
Presenters(s): David J. Minion, M.D. | |
10:57 AM - 11:03 AM | Role Of Lasers In The Treatment Of Lower Extremity Occlusive Disease: Is There A Place After All? |
Presenters(s): John R. Laird, M.D. | |
11:04 AM - 11:14 AM | Panel Discussion |
END OF SESSION X |